Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/alebunds-innovative-investigational-drug-ap303-receives-fda-orphan-drug-designation-odd-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-302101896.html
https://www.prnewswire.com/news-releases/alebund-reports-update-for-ap306-eos789-a-first-in-class-pan-inhibitor-of-sodium-dependent-phosphate-transporters-from-a-completed-phase-ii-clinical-trial-in-patients-with-hyperphosphatemia-on-hemodialysis-302013538.html
https://www.biocentury.com/article/640122/lav-s-xia-parlays-gap-in-kidney-therapies-into-china-start-up
https://endpts.com/shanghai-biotech-tackling-kidney-disease-gets-another-round-of-cash/
https://www.prnewswire.com/news-releases/alebund-pharmaceuticals-raises-54-5-million-in-series-b-financing-round-to-fuel-development-of-renal-disease-treatment-301375130.html